Importantly, CD44v6-knockdown xenografts displayed a significant decrease in tumor growth, accompanied by reduced CD44v6 and ERK1/2 levels, thereby utilizing yet another cooperative mechanism with binding partners for anti-apoptotic signaling promotion (Figure 6C; Chen et al., 2023). This evidence concerns the gene MAPK3 and neoplasm.